FGF23 and cardiac hypertrophy: In pathological scenarios of massive FGF23 elevations, such as CKD, FGF23 can bind and activate FGFR4 in a klotho-independent manner, thereby stimulating phospholipase Cγ (PLCγ)/calcineurin signaling and causing pathologic alterations, such as cardiac hypertrophy [287].